This inventor holds 1 USPTO granted patent. Top assignee: Becton Dickinson and Company Limited. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: David J Antol: Innovator in Nucleic Acid Diagnostics
Introduction
David J Antol is a notable inventor based in Baldwin, MD (US). He has made significant contributions to the field of diagnostics, particularly through his innovative work in nucleic acid-based assays. His expertise and inventions have paved the way for advancements in automated diagnostic systems.
Latest Patents
David J Antol holds a patent for a "System for nucleic acid based diagnostic assay." This automated system is designed to perform nucleic acid-based assays on multiple liquid samples with minimal human intervention. The system features a reaction station that applies controlled heat to various reaction devices, facilitating the movement of liquid samples through pneumatic ports. The robotically controlled aspiration and dispensing head enhances the efficiency of sample handling, allowing for precise movements and the introduction of reagents.
Career Highlights
Antol's career is marked by his role at Becton Dickinson and Company Limited, where he has contributed to the development of cutting-edge diagnostic technologies. His work has been instrumental in improving the accuracy and efficiency of nucleic acid testing, which is crucial for various medical applications.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Scott D Hildebrand and Michael L Lamos. These partnerships have fostered innovation and have been vital in advancing the technologies developed at Becton Dickinson.
Conclusion
David J Antol's contributions to the field of nucleic acid diagnostics exemplify the impact of innovative thinking in healthcare. His patented systems are a testament to his dedication to improving diagnostic processes, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
